BioHarvest Sciences Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • BioHarvest Sciences's estimated annual revenue is currently $2.9M per year.(i)
  • BioHarvest Sciences's estimated revenue per employee is $162,000

Employee Data

  • BioHarvest Sciences has 18 Employees.(i)
  • BioHarvest Sciences grew their employee count by -5% last year.

BioHarvest Sciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CTOReveal Email/Phone
3
VP, Global Marketing & PartnershipsReveal Email/Phone
4
Head Marketing and Business Development - USAReveal Email/Phone
5
Head Investor RelationsReveal Email/Phone
6
VP R&DReveal Email/Phone
7
DirectorReveal Email/Phone
8
Strategic Procurement & IT DirectorReveal Email/Phone
9
Director EngineeringReveal Email/Phone
10
Sales and Customer Success ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$409M108215%N/AN/A
#2
$5.5M29-15%N/AN/A
#3
$31.3M116-13%N/AN/A
#4
$14.8M61-18%N/AN/A
#5
$13.1M548%N/AN/A
#6
$34.3M1274%N/AN/A
#7
$219.4M65017%N/AN/A
#8
$505.4M133722%N/AN/A
#9
$31.3M11627%N/AN/A
#10
$123.2M36513%N/AN/A
Add Company

What Is BioHarvest Sciences?

BioHarvest employs a revolutionary proprietary technology centred on growing fruit cells as a natural source for specific and highly beneficial nutritional ingredients. Rather than being isolated, the ingredients reside in their natural state ensuring maximum potency.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.9M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioHarvest Sciences News

2022-03-30 - Bioharvest Sciences Completes R&D Program, Produces Cannabis Biomass In Bioreactor - Benzinga

BioHarvest Sciences Inc.'s. CNVCF · BHSC. (FSE:8MV) sales of its flagship VINIA product in Q1 2022 reached $787K, representing 112% growth...

2022-03-30 - BioHarvest Sciences Announces A Private Placement Of Up To $5M Of Convertible Notes - Benzinga

BioHarvest Sciences Inc. CNVCF · BHSC. (FSE:8MV) announced a financing plan based on a private placement of up to $5 million.

2022-03-30 - BioHarvest Sciences Inc. Announces a Private Placement of up to USD $5 Million of Convertible Notes to Finance Production Facilities and Scaling of Core Business

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - April 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC:CNVCF) (FSE:...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M18-33%N/A
#2
$2.4M18-28%N/A
#3
$2.7M18-14%N/A
#4
$2.2M18N/AN/A
#5
$1.6M18N/AN/A